Overview
Why Invest in CNBS ETF?
- Green Rush Growth Potential: In the U.S., sales of legal recreational cannabis are expected to grow from $32.1 billion in 2024 to reach nearly $58 billion by 2030.1
- Active Management: Allows for timely decisions in this dynamic space. Tim Seymour is an experienced investor and recognized voice in the cannabis sector.
- Convenient Access: Through a single ETF, gain convenient access to a basket of companies across the cannabis and hemp ecosystem.
Objective & Strategy
CNBS is an actively managed ETF that provides diversified U.S. exposure across the cannabis ecosystem including cannabis: plants, support, and ancillary businesses. CNBS seeks to provide capital appreciation.
- The Cannabis Recap - June 18, 2026
Audio Commentary by Tim Seymour
Key Information
Fund Details
Fees & Expenses
| Management Fee | 0.65% |
| Other Expenses | 0.43% |
| Acquired Fund Fees & Expenses | 0.01% |
| Total Annual Fund Operating Expenses | 1.09% |
| Less Waiver/Reimbursement | 0.33%The Fund’s investment adviser has contractually agreed to waive its advisory fees and/or assume as its own expense certain expenses otherwise payable by the Fund to the extent necessary to ensure that total annual fund operating expenses do not exceed 0.75% of average daily net assets until March 1, 2027. |
| Net Expense Ratio | 0.76%As of most recent prospectus |
Portfolio Management
Active Management Selection Process
CNBS invests at least 80% of its assets in securities of U.S. companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem, across one of three classifications:
Cannabis/Hemp Plant
- Pharma/BioTech
- Cultivation & Retail
- Hemp Products
- Cannabis-infused Products
Suport
- Agricultural Tech
- Real Estate
- Commercial Services
Ancillary
- Consumption Devices
- Investing & Finance
- Tech & Media
Performance & Holdings
Performance
The performance data quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted. Brokerage commissions will reduce returns. NAV is the sum of all its assets less any liabilities, divided by the number of shares outstanding. The closing price is the last price at which the fund traded.
Top 10 Holdings
Fund holdings are subject to change at any time and should not be considered recommendations to buy or sell any security.
Allocation
Distributions
There is no guarantee that distributions will be made.
Effective on February 21, 2025, the Fund participated in a reverse share split ratio of 1 for 12.
Price
NAV/Market Price
Daily Price/NAV Performance
Effective on February 21, 2025, the Fund participated in a reverse share split ratio of 1 for 12.
Premium/Discount
The table and line graph are provided to show the frequency at which the closing price of the Fund was at a premium (above) or discount (below) to the Fund’s daily net asset value (“NAV”). The table and line graph represent past performance and cannot be used to predict future results. Shareholders may pay more than NAV when buying Fund shares and receive less than an NAV when those shares are sold because shares are bought and sold at current market prices.
Literature
Fund Resources
Insights
The Cannabis Recap - June 18, 2026
June 18, 2026
Audio Commentary by Tim Seymour
The Cannabis Recap - June 15, 2026
June 15, 2026
Audio Commentary by Tim Seymour
The Cannabis Recap - June 1, 2026
June 1, 2026
Audio Commentary by Tim Seymour
How to Invest
Amplify ETFs trade throughout the day, similar to publicly-traded stocks, on an exchange. There are multiple ways to invest in Amplify ETFs:
- Contact a Financial Advisor to discover how Amplify ETFs may fit within your portfolio.
- Amplify ETFs are available through various online platforms and brokerage accounts.
Connect with your ETF Specialst or call (855) 267-3837
1statista.com/markets/415/topic/2436cannabis/#statistic1
Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV, and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.
The Fund is subject to management risk because it is an actively managed. Companies involved in the cannabis industry face competition, may have limited access to the services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement actions, and are heavily dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. The possession and use of cannabis, even for medical purposes, is illegal under federal and certain states’ laws, which may negatively impact the value of the Fund’s investments. Securities issued by non-U.S. companies present risks beyond those of securities of U.S. issuers.
Many of the companies in which the Fund will invest are engaged in other lines of business unrelated to cannabis and these lines of business could adversely affect their operating results. Cannabis is a Schedule I controlled substance under the Controlled Substances Act (“CSA”), meaning that it has a high potential for abuse, has no currently “accepted medical use” in the U.S., lacks accepted safety for use under medical supervision, and may not be prescribed, marketed or sold in the U.S. Small and/or mid-capitalization companies may be more vulnerable to adverse general market or economic developments, and their securities may be less liquid and may experience greater price volatility than larger, more established companies as a result of several factors, including limited trading volumes, products or financial resources, management inexperience and less publicly available information. The Fund is non-diversified, which can cause greater share price fluctuation.
Amplify Investments LLC serves as the investment adviser to the Fund. Seymour Asset Management LLC and Tidal Financial LLC serve as investment sub-advisers to the Fund.
Amplify ETFs are distributed by Foreside Fund Services, LLC.